Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason B Williams

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cell Reports|August 23, 2018
Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and ToleranceMichelle L Miller, Christine M McIntosh, Jason B Williams, et al.
Scientific Reports|July 21, 2022
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cellsChristina Martins, Mariana Silva, Erik Rasbach, et al.
Science (New York, N.Y.)|November 7, 2015
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacyAyelet Sivan, Leticia Corrales, Nathaniel Hubert, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Resident memory T cell development is associated with AP-1 transcription factor upregulation across anatomical nichesNeal P Smith, Yu Yan, Youdong Pan, et al.
JCI Insight|June 23, 2025
Resident memory T cell development is gradual and shows AP-1 gene expression in mature cellsNeal P Smith, Yu Yan, Youdong Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2012
IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapyErica G Schmitt, Dipica Haribhai, Jason B Williams, et al.
Immunity|July 5, 2011
A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversityDipica Haribhai, Jason B Williams, Shuang Jia, et al.
Cancer Research|October 2, 2020
Epigenetic Control of <i>Cdkn2a.Arf</i> Protects Tumor-Infiltrating Lymphocytes from Metabolic ExhaustionBrian Koss, Bradley D Shields, Erin M Taylor, et al.
Nature Immunology|January 16, 2019
Thymic regulatory T cells arise via two distinct developmental programsDavid L Owen, Shawn A Mahmud, Louisa E Sjaastad, et al.
Molecular Cancer|December 18, 2025
Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progressionErik Rasbach, Laure Migayron, Anne Brandenburg, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cell Reports|August 23, 2018
Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and ToleranceMichelle L Miller, Christine M McIntosh, Jason B Williams, et al.
Scientific Reports|July 21, 2022
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cellsChristina Martins, Mariana Silva, Erik Rasbach, et al.
Science (New York, N.Y.)|November 7, 2015
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacyAyelet Sivan, Leticia Corrales, Nathaniel Hubert, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Resident memory T cell development is associated with AP-1 transcription factor upregulation across anatomical nichesNeal P Smith, Yu Yan, Youdong Pan, et al.
JCI Insight|June 23, 2025
Resident memory T cell development is gradual and shows AP-1 gene expression in mature cellsNeal P Smith, Yu Yan, Youdong Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2012
IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapyErica G Schmitt, Dipica Haribhai, Jason B Williams, et al.
Immunity|July 5, 2011
A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversityDipica Haribhai, Jason B Williams, Shuang Jia, et al.
Cancer Research|October 2, 2020
Epigenetic Control of <i>Cdkn2a.Arf</i> Protects Tumor-Infiltrating Lymphocytes from Metabolic ExhaustionBrian Koss, Bradley D Shields, Erin M Taylor, et al.
Nature Immunology|January 16, 2019
Thymic regulatory T cells arise via two distinct developmental programsDavid L Owen, Shawn A Mahmud, Louisa E Sjaastad, et al.
Molecular Cancer|December 18, 2025
Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progressionErik Rasbach, Laure Migayron, Anne Brandenburg, et al.
Pageof 3